| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |